• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session

    11/2/22 1:28:02 PM ET
    $ABNB
    $ACIW
    $AHG
    $ARCT
    Diversified Commercial Services
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology
    Get the next $ABNB alert in real time by email

    Gainers

    • Starry Group Holdings, Inc. (NYSE:STRY) gained 56% to $0.2808 after reporting Q3 results.
    • Benefitfocus, Inc. (NASDAQ:BNFT) shares jumped 47.8% to $10.33 after the company announced it will be acquired by Voya Financial for $10.50 per share.
    • Akso Health Group (NASDAQ:AHG) gained 44% to $0.7280.
    • Rayonier Advanced Materials Inc. (NYSE:RYAM) shares climbed 40.9% to $6.30 as the company posted upbeat quarterly results.
    • Forza X1, Inc. (NASDAQ:FRZA) jumped 39% to $2.3495 after the company announced it received 50 electric boat reservations in the last 90 days, potentially resulting in over $8.5 million in revenue.
    • Bandwidth Inc. (NASDAQ:BAND) gained 36.9% to $16.84 after the company reported better-than-expected Q3 sales results. The company also issued Q4 and FY22 sales guidance above analyst estimates.
    • Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) shares rose 32.8% to $24.30 after the company announced collaboration with CSL to develop and commercialize self-amplifying mRNA vaccines. Arcturus to receive upfront payment of $200 million.
    • Lindblad Expeditions Holdings, Inc. (NASDAQ:LIND) jumped 31.1% to $10.91 following strong Q3 results.
    • Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) gained 29.3% to $3.22.
    • Huadi International Group Co., Ltd. (NASDAQ:HUDI) surged 29.3% to $32.88.
    • Chegg, Inc. (NYSE:CHGG) rose 24.2% to $26.23 after the company reported better-than-expected Q3 results. The company also issued FY22 sales guidance above analyst estimates.
    • electroCore, Inc. (NASDAQ:ECOR) jumped 21% to $0.3568.
    • Sun Country Airlines Holdings, Inc. (NASDAQ:SNCY) gained 19.5% to $19.56 following Q3 results.
    • Cocrystal Pharma, Inc. (NASDAQ:COCP) rose 17.3% to $2.83. Cocrystal Pharma was granted European patent covering oral antiviral candidate CC-42344 in combination with another antiviral agent for the treatment of influenza.
    • Quad/Graphics, Inc. (NYSE:QUAD) gained 17.1% to $3.15 after the company reported Q3 EPS and sales results up from last year. The company also raised its FY22 sales growth expectations.
    • trivago N.V. (NASDAQ:TRVG) jumped 16.8% to $1.2150.
    • 9F Inc. (NASDAQ:JFU) gained 16.3% to $0.2620.
    • Codiak BioSciences, Inc. (NASDAQ:CDAK) jumped 16.2% to $0.8950.
    • Super Micro Computer, Inc. (NASDAQ:SMCI) rose 16% to $83.38 after the company reported better-than-expected Q3 EPS and sales results.
    • VEON Ltd. (NASDAQ:VEON) jumped 15.7% to $0.4050. VEON said it is conducting a sale process for its Russian operations.
    • OneSpan Inc. (NASDAQ:OSPN) gained 14.8% to $11.94 following Q3 results.
    • Li Auto Inc. (NASDAQ:LI) jumped 13.5% to $16.53.
    • RLX Technology Inc. (NYSE:RLX) rose 13.3% to $1.5527 after climbing around 10% on Tuesday.
    • Meta Materials Inc. (NASDAQ:MMAT) jumped 12.2% to $1.2950.
    • Mercury General Corporation (NYSE:MCY) gained 11.1% to $32.18 following strong quarterly earnings.
    • Cano Health, Inc. (NYSE:CANO) surged 11% to $3.6950.
    • Service Corporation International (NYSE:SCI) rose 11% to $67.88 after the company reported better-than-expected Q3 EPS and sales results. The company also raised its FY22 EPS guidance above analyst estimates.
    • The Lion Electric Company (NYSE:LEV) gained 10.7% to $3.3106. Lion Electric announced the production of its first Made In America school bus in its Joliet Illinois Factory.
    • Li Auto Inc (NASDAQ:LI) rose 10.4% to $16.08. Li Auto recently reported it delivered 10,052 vehicles in October 2022, up 31.4% year over year.
    • PROS Holdings, Inc. (NYSE:PRO) gained 9.5% to $27.29 after posting upbeat quarterly results.
    • United Therapeutics Corporation (NASDAQ:UTHR) surged 9% to $249.02 after the company reported better-than-expected Q3 results.
    • Charles River Laboratories International, Inc. (NYSE:CRL) jumped 8.8% to $225.60 after the company reported better-than-expected Q3 results.
    • Yum China Holdings, Inc. (NYSE:YUMC) rose 6.7% to $45.96 after reporting a rise in Q3 earnings.
    • Match Group, Inc. (NASDAQ:MTCH) shares rose 5.9% to $46.47 after the company reported better-than-expected Q3 results.


    Losers

    • Rogers Corporation (NYSE:ROG) shares dipped 44.2% to $128.18 after Dupont announced it is terminating its intended acquisition of the company.
    • Tupperware Brands Corporation (NYSE:TUP) fell 43.2% to $4.39 after the company reported worse-than-expected Q3 results. The company said inability to maintain compliance with covenants in its credit agreement raises substantial doubt about its ability to continue as a going concern.
    • Enovix Corporation (NASDAQ:ENVX) fell 42.2% to $10.39 after the company reported worse-than-expected Q3 EPS.
    • TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) fell 38.2% to $1.67 after the company announced program updates for Voriconazole Inhaled Powder and Tacrolimus Inhaled Powder clinical programs.
    • Resideo Technologies, Inc. (NYSE:REZI) dropped 30.2% to $16.31 after the company reported worse-than-expected Q3 EPS and sales results.
    • Omnicell, Inc. (NASDAQ:OMCL) fell 24.6% to $57.60 after the company reported worse-than-expected Q3 sales results and issued Q4 and FY22 EPS and sales guidance below estimates.
    • G1 Therapeutics, Inc. (NASDAQ:GTHX) dropped 23.8% to $8.31 after reporting Q3 results. G1 Therapeutics also described safety data from the first 18 patients enrolled in its ongoing Phase 2 study of trilaciclib administered before sacituzumab govitecan-hziy in patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC).
    • ZoomInfo Technologies Inc. (NASDAQ:ZI) fell 22.2% to $33.83 as the company posted upbeat Q3 earnings, but lowered its free-cash flow outlook.
    • Selina Hospitality PLC (NASDAQ:SLNA) dipped 21.9% to $7.76.
    • Vyant Bio, Inc. (NASDAQ:VYNT) shares fell 21% to $1.50. Vyant Bio announced a one-for-five reverse stock split.
    • Computer Programs and Systems, Inc. (NASDAQ:CPSI) dropped 18.4% to $26.17 following downbeat earnings.
    • Global Industrial Company (NYSE:GIC) dipped 18.1% to $25.46 following weak quarterly earnings.
    • TravelCenters of America Inc. (NASDAQ:TA) fell 17.7% to $52.53 after the company reported worse-than-expected Q3 EPS.
    • Donnelley Financial Solutions, Inc. (NYSE:DFIN) dropped 17.3% to $34.33 following downbeat earnings.
    • Avient Corporation (NYSE:AVNT) dipped 17% to $29.08 after the company reported worse-than-expected Q3 sales results and cut its FY22 EPS guidance below analyst estimates.
    • Regional Management Corp. (NYSE:RM) dropped 16.3% to $28.88 following Q3 results.
    • Materion Corporation (NYSE:MTRN) fell 15.2% to $72.86 following weak quarterly earnings.
    • Kaman Corporation (NASDAQ:KAMN) fell 13.8% to $27.81 following downbeat quarterly results.
    • Mirion Technologies, Inc. (NYSE:MIR) declined 13.8% to $6.61 amid downbeat quarterly earnings.
    • Skyline Champion Corporation (NYSE:SKY) dropped 13.5% to $49.00 after the company reported Q2 financial results.
    • PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) fell 12.6% to $0.0830. PhaseBio Pharmaceuticals reported it received notice from Nasdaq stating it has determined that the company's securities will be delisted from Nasdaq.
    • ATI Inc. (NASDAQ:ATI) fell 12.6% to $27.17 after the company reported Q3 financial results.
    • Xenia Hotels & Resorts, Inc. (NYSE:XHR) dropped 12.1% to $15.03 following Q3 results.
    • RXO Inc (NYSE:RXO) dipped 11.9% to $16.78.
    • Entegris, Inc. (NASDAQ:ENTG) fell 11.7% to $70.99 after the company reported worse-than-expected Q3 EPS and sales results and issued Q4 EPS and sales guidance below estimates.
    • Paramount Global (NASDAQ:PARA) dipped 11.3% to $17.00 after the company reported worse-than-expected Q3 EPS and sales results.
    • Safe-T Group Ltd (NASDAQ:SFET) fell 10.7% to $0.35. Safe-T Group shares gained over 30% on Tuesday as the company said its privacy application reached over 5,000,000 downloads.
    • ACI Worldwide, Inc. (NASDAQ:ACIW) dropped 10.4% to $22.07 after the company reported worse-than-expected Q3 sales results.
    • Jones Lang LaSalle Incorporated (NYSE:JLL) dropped 10.4% to $144.99 after the company reported worse-than-expected Q3 EPS results.
    • Airbnb, Inc. (NASDAQ:ABNB) fell 9% to $99.25 following Q3 results. The company said it expects nights and experiences booked growth will moderate slightly relative to Q3 and Average Daily Rates will face pressures from forex headwinds and business mix.
    Get the next $ABNB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABNB
    $ACIW
    $AHG
    $ARCT

    CompanyDatePrice TargetRatingAnalyst
    Avient Corporation
    $AVNT
    3/4/2026Overweight → Sector Weight
    KeyBanc Capital Markets
    Enovix Corporation
    $ENVX
    2/26/2026$15.00 → $7.50Hold
    TD Cowen
    Airbnb Inc.
    $ABNB
    2/13/2026$145.00In-line → Outperform
    Evercore ISI
    Airbnb Inc.
    $ABNB
    2/13/2026$154.00Hold → Buy
    Deutsche Bank
    Sun Country Airlines Holdings Inc.
    $SNCY
    2/10/2026$18.00 → $22.00Buy
    TD Cowen
    Li Auto Inc.
    $LI
    2/9/2026$14.00Neutral → Underweight
    Analyst
    Entegris Inc.
    $ENTG
    2/4/2026$105.00Buy → Hold
    Deutsche Bank
    Omnicell Inc.
    $OMCL
    2/4/2026$70.00Neutral → Buy
    BofA Securities
    More analyst ratings

    $ABNB
    $ACIW
    $AHG
    $ARCT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for COSELA

    Submission status for G1 THERAPEUTICS INC's drug COSELA (ORIG-1) with active ingredient TRILACICLIB DIHYDROCHLORIDE has changed to 'Approval' on 02/12/2021. Application Category: NDA, Application Number: 214200, Application Classification: Type 1 - New Molecular Entity

    2/16/21 4:31:16 PM ET
    $GTHX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for COSELA

    Submission status for G1 THERAPEUTICS INC's drug COSELA (ORIG-1) with active ingredient TRILACICLIB has changed to 'Approval' on 02/12/2021. Application Category: NDA, Application Number: 214200, Application Classification: Type 1 - New Molecular Entity

    2/16/21 11:21:53 AM ET
    $GTHX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    February 12, 2021 - FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy

    For Immediate Release: February 12, 2021 Today, the U.S. Food and Drug Administration approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression in adults receiving certain types of chemotherapy for extensive-stage (when the cancer has spread beyond the lungs) small cell lung cancer. Cosela may help protect bone marrow cells from damage caused by chemotherapy by inhi

    2/12/21 5:24:11 PM ET
    $GTHX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABNB
    $ACIW
    $AHG
    $ARCT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Global investor bidding activity converges across property sectors

    Bidding competitiveness across the four main property sectors converges to the narrowest  spread in over three years, signaling a more normalized and balanced market in 2026CHICAGO, March 10, 2026 /PRNewswire/ -- Investment bidding intensity in the commercial real estate market is holding steady and buyer interest remains competitive across property types, even with the supply of investment opportunities increasing. This is according to JLL's Global Bid Intensity Index, a leading indicator for future capital flows that offers a real-time view on liquidity dynamics across global private real estate capital markets through analysis of the firm's proprietary investor bidding data. Despite the r

    3/10/26 12:04:00 PM ET
    $JLL
    Real Estate
    Finance

    1.2 Million EVs Sold In the U.S. Last Year; Spring Break Road Trips Are Going Electric

    With travel season beginning in mid-March across much of the U.S., Mercury Insurance shares smart charging and safety tips for families hitting the roadLOS ANGELES, March 10, 2026 /PRNewswire/ -- Spring Break doesn't arrive all at once. From Florida beaches in early March to West Coast road trips in April, school calendars across the country stagger the season — but for many families, travel typically ramps up in mid-March. And increasingly, those trips are happening behind the wheel of an electric vehicle — a trend Mercury Insurance (NYSE/NYSE Texas: MCY) is closely tracking as EV ownership continues to grow nationwide.More than 1.2 million electric vehicles were sold in the U.S. in 2025, m

    3/10/26 12:00:00 PM ET
    $MCY
    Property-Casualty Insurers
    Finance

    CHARNEY COMPANIES, TAVROS, AND CANYON PARTNERS REAL ESTATE SECURE $125.536M FINANCING FOR GOWANUS' AMENITY-LADEN NINE-STORY RENTAL BUILDING, UNION CHANNEL

    JLL Capital Markets arranged Freddie Mac refinancing for 224-unit building, the first of four Gowanus Wharf ResidencesNEW YORK, March 10, 2026 /PRNewswire/ -- Joint partners, Charney Companies, Tavros and Canyon Partners Real Estate today announced that they have secured $125.536 million in fixed-rate financing for Union Channel, a 224-residential rental building in the burgeoning community of Gowanus Brooklyn. The trophy building, with an abundance of amenities, wonderful views and spacious, well-designed apartments, is the first of the four new buildings that make up the campus of Gowanus Wharf.

    3/10/26 11:07:00 AM ET
    $JLL
    Real Estate
    Finance

    $ABNB
    $ACIW
    $AHG
    $ARCT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Chakravarthy Arthi covered exercise/tax liability with 894 shares, decreasing direct ownership by 0.20% to 457,203 units (SEC Form 4)

    4 - Enovix Corp (0001828318) (Issuer)

    3/10/26 7:07:17 PM ET
    $ENVX
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 4 filed by Enovix Corporation

    4 - Enovix Corp (0001828318) (Issuer)

    3/10/26 7:07:33 PM ET
    $ENVX
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 4 filed by ACI Worldwide Inc.

    4 - ACI WORLDWIDE, INC. (0000935036) (Issuer)

    3/10/26 5:38:42 PM ET
    $ACIW
    Computer Software: Prepackaged Software
    Technology

    $ABNB
    $ACIW
    $AHG
    $ARCT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Corp Strategy & Develop Laplume Joseph W bought $4,364 worth of shares (25 units at $174.54), increasing direct ownership by 0.09% to 27,448 units (SEC Form 4)

    4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)

    3/4/26 4:39:28 PM ET
    $CRL
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Director Zenner Marc bought $34,782 worth of shares (3,300 units at $10.54), increasing direct ownership by 4% to 83,208 units (SEC Form 4)

    4 - OneSpan Inc. (0001044777) (Issuer)

    3/4/26 4:30:16 PM ET
    $OSPN
    EDP Services
    Technology

    Director Benitez Juan Ii bought $100,551 worth of shares (2,400 units at $41.90), increasing direct ownership by 17% to 16,881 units (SEC Form 4)

    4 - ACI WORLDWIDE, INC. (0000935036) (Issuer)

    3/4/26 6:08:11 AM ET
    $ACIW
    Computer Software: Prepackaged Software
    Technology

    $ABNB
    $ACIW
    $AHG
    $ARCT
    SEC Filings

    View All

    SEC Form 144 filed by Lindblad Expeditions Holdings Inc.

    144 - LINDBLAD EXPEDITIONS HOLDINGS, INC. (0001512499) (Subject)

    3/10/26 4:51:04 PM ET
    $LIND
    Transportation Services
    Consumer Discretionary

    SEC Form 10-K filed by Chegg Inc.

    10-K - CHEGG, INC (0001364954) (Filer)

    3/9/26 5:23:11 PM ET
    $CHGG
    Other Consumer Services
    Real Estate

    United Therapeutics Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - UNITED THERAPEUTICS Corp (0001082554) (Filer)

    3/9/26 5:18:10 PM ET
    $UTHR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABNB
    $ACIW
    $AHG
    $ARCT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Avient downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Avient from Overweight to Sector Weight

    3/4/26 8:31:02 AM ET
    $AVNT
    Major Chemicals
    Industrials

    TD Cowen reiterated coverage on Enovix with a new price target

    TD Cowen reiterated coverage of Enovix with a rating of Hold and set a new price target of $7.50 from $15.00 previously

    2/26/26 6:56:07 AM ET
    $ENVX
    Industrial Machinery/Components
    Miscellaneous

    Airbnb upgraded by Evercore ISI with a new price target

    Evercore ISI upgraded Airbnb from In-line to Outperform and set a new price target of $145.00

    2/13/26 8:19:37 AM ET
    $ABNB
    Diversified Commercial Services
    Consumer Discretionary

    $ABNB
    $ACIW
    $AHG
    $ARCT
    Leadership Updates

    Live Leadership Updates

    View All

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    MeetKai and GSMA Present ModelChorus at MWC26 Barcelona

    New global platform enables users to prompt and evaluate AI Models for under-resourced languages and regional dialectsBARCELONA, Spain, March 4, 2026 /PRNewswire/ -- MeetKai Inc. and the GSMA today announced their collaboration to launch ModelChorus, a new online platform designed to help mobile operators, model developers, and ecosystem partners evaluate language models and accelerate deployment of language ready AI across real world networks and devices. Visitors to MWC26 Barcelona can experience ModelChorus at the GSMA Pavilion in Hall 4 (Stand 4F30) at Fira Barcelona Gran Via or visit an alpha version of ModelChorus at www.modelchorus.com.

    3/4/26 9:00:00 AM ET
    $VEON
    Telecommunications Equipment
    Telecommunications

    Charles River Laboratories Announces Executive Appointments

    Glenn G. Coleman Will Join Charles River as Corporate Executive Vice President and Chief Financial Officer Kerry Dailey Will Join Charles River as Corporate Senior Vice President and Chief Legal Officer Charles River Laboratories International, Inc. (NYSE:CRL) today announced two executive appointments: Glenn G. Coleman has been named the Company's next Chief Financial Officer and Kerry Dailey has been named to the newly-created position of Chief Legal Officer. Birgit Girshick, Corporate Executive Vice President, Chief Operating Officer and incoming Chief Executive Officer, commented, "We are very pleased to welcome Kerry Dailey and Glenn Coleman in two key executive roles, as we stre

    2/18/26 7:01:00 AM ET
    $CRL
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $ABNB
    $ACIW
    $AHG
    $ARCT
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Stock Movement: Insider Purchase at electroCore Inc. on Jun 6

    **Analysis of Recent Insider Purchase at electroCore Inc.** An insider purchase was recently made at electroCore Inc. by Goldberger Daniel S on June 6, 2024. This transaction involved the purchase of $247,587 worth of shares, equating to 38,505 units at an average price of $6.43 per share. As a result of this purchase, Goldberger's direct ownership in the company increased by 18% to 249,565 units, as reported in the SEC Form 4 filing. Looking at the historical insider transactions at electroCore Inc., several interesting patterns emerge when analyzing the timing, price, volume, purchaser's role, and more. On August 8, 2023, Goldstein Julie Ann and Cuneo F Peter both filed SEC Form 4 report

    6/10/24 12:57:57 AM ET
    $ECOR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ABNB
    $ACIW
    $AHG
    $ARCT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Resideo Technologies Inc.

    SC 13D/A - RESIDEO TECHNOLOGIES, INC. (0001740332) (Subject)

    11/27/24 4:38:57 PM ET
    $REZI
    Wholesale Distributors
    Industrials

    Amendment: SEC Form SC 13G/A filed by TFF Pharmaceuticals Inc.

    SC 13G/A - TFF Pharmaceuticals, Inc. (0001733413) (Subject)

    11/19/24 4:05:58 PM ET
    $TFFP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Quad Graphics Inc

    SC 13G/A - Quad/Graphics, Inc. (0001481792) (Subject)

    11/14/24 5:29:24 PM ET
    $QUAD
    Publishing
    Consumer Discretionary

    $ABNB
    $ACIW
    $AHG
    $ARCT
    Financials

    Live finance-specific insights

    View All

    RYAM Reports Fourth Quarter 2025 Results

    Net Sales for the fourth quarter of $417 million, down $5 million from prior year quarter Loss from Continuing Operations for the fourth quarter of $21 million, a decline of $5 million from prior year quarter Adjusted EBITDA from Continuing Operations for the fourth quarter of $46 million, down $5 million from prior year quarter Total Debt of $779 million and Net Secured Debt of $715 million with a covenant net secured leverage ratio of 3.9 times Year-to-date Cash Provided by Operating Activities of $24 million; negative Adjusted Free Cash Flow of $88 million Rayonier Advanced Materials Inc. (NYSE:RYAM) (the "Company") today reported results for its fourth quarter and year e

    3/3/26 4:15:00 PM ET
    $RYAM
    Paper
    Basic Materials

    Regional Management Corp. and Column N.A. Announce New Lending Partnership to Support Growth and Returns

    Regional Management Corp. (NYSE:RM), a diversified consumer finance company operating under the name "Regional Finance" across 19 states, announced today a new lending partnership with Column N.A., a nationally chartered bank built to enable developers and builders to create financial products. Column will serve as a bank partner for Regional's secured and unsecured installment lending products in select states. The partnership launched this week and will support Regional's continued growth, as well as enhance its ability to enter new markets and expand its product offerings over time. "As we continue to grow our business and serve our customers' varied financial needs, we are excited t

    3/3/26 4:15:00 PM ET
    $RM
    Finance: Consumer Services
    Finance

    Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress

    ARCT-032 (CF) Phase 2 third cohort (28 days, 15 mg) generally safe and well tolerated ARCT-032 permitted to proceed into 12-week Phase 2 study; dosing to begin H1 2026 Cash runway extended into Q2 2028 Investor conference call at 4:30 p.m. ET today Arcturus Therapeutics Holdings Inc. ((the "Company", "Arcturus", NASDAQ:ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today announced its financial results for the fourth quarter and fiscal year 2025, and provided corporate updates. "Arcturus continues to progress its rare disease therapeutic portfolio. We look forward to aligning with regulators on our clinical d

    3/3/26 4:01:00 PM ET
    $ARCT
    Biotechnology: Pharmaceutical Preparations
    Health Care